Search Results - "Labrot E"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Contribution and clinical relevance of germline variation to the cancer transcriptome.

    Authors: Pereira B Labrot E Durand E et al.

    Source: BMC cancer [BMC Cancer] 2022 Jun 20; Vol. 22 (1), pp. 675. Date of Electronic Publication: 2022 Jun 20.

    Publication Type: Journal Article

    Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    Integrated CRISPR screening and drug profiling identifies combination opportunities for EGFR, ALK, and BRAF/MEK inhibitors.

    Authors: Tiedt R King FJ Stamm C et al.

    Source: Cell reports [Cell Rep] 2023 Apr 25; Vol. 42 (4), pp. 112297. Date of Electronic Publication: 2023 Mar 23.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

    Save to List
  3. 3

    Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.

    Authors: Pitt JJ Riester M Zheng Y et al.

    Source: Nature communications [Nat Commun] 2019 Jan 14; Vol. 10 (1), pp. 288. Date of Electronic Publication: 2019 Jan 14.

    Publication Type: Journal Article; Published Erratum

    Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: PubMed not MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features.

    Authors: Pitt JJ Riester M Zheng Y et al.

    Source: Nature communications [Nat Commun] 2018 Oct 16; Vol. 9 (1), pp. 4181. Date of Electronic Publication: 2018 Oct 16.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  5. 5

    LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors.

    Authors: Monaco KA Delach S Yuan J et al.

    Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Apr 01; Vol. 27 (7), pp. 2061-2073. Date of Electronic Publication: 2020 Dec 22.

    Publication Type: Journal Article

    Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

    Save to List
  6. 6

    Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer.

    Authors: Raoof S Mulford IJ Frisco-Cabanos H et al.

    Source: Oncogene [Oncogene] 2019 Sep; Vol. 38 (37), pp. 6399-6413. Date of Electronic Publication: 2019 Jul 19.

    Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

    Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE

    Save to List
  7. 7

    SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.

    Authors: Dardaei L Wang HQ Singh M et al.

    Source: Nature medicine [Nat Med] 2018 May; Vol. 24 (4), pp. 512-517. Date of Electronic Publication: 2018 Mar 05.

    Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

    Save to List

Search Tools: